Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh enzim CYP3A4 dan CYP2C8. Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes mellitus. Repaglinide is...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/29661/1/Population_pharmacokinetics_of_repaglinide_in_heal_thy_subjects_and_genetic_pol_ymorphisms_of_CYP3A4_AND_CYP2CB___________________________f.pdf http://eprints.usm.my/29661/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat
penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh
enzim CYP3A4 dan CYP2C8.
Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of
type 2 diabetes mellitus. Repaglinide is mainly metabolised in the liver by CYP3A4
and CYP2C8 enzymes.
|
|---|